Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paoletti

Showing results (141-150 of 210) with videos related to

Pageof 21
Sort By:
Contributions to Nephrology|January 1, 1987
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestionG Deferrari, G Garibotto, C Robaudo, et al.
Virology|November 1, 1991
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virusE Konishi, S Pincus, B A Fonseca, et al.
Veterinary Microbiology|December 1, 1993
Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant virusesS L Brockmeier, K M Lager, J Tartaglia, et al.
Vaccine|August 1, 1995
Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidateE Gönczöl, K Berensci, S Pincus, et al.
Journal of Virology|January 1, 1995
Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 geneE Beattie, K L Denzler, J Tartaglia, et al.
Virology|September 1, 1992
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swineE Konishi, S Pincus, E Paoletti, et al.
The Journal of Infectious Diseases|June 1, 1987
Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein DM Wachsman, L Aurelian, C C Smith, et al.
Virology|December 1, 1990
Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase geneC Edbauer, R Weinberg, J Taylor, et al.
Vaccine|April 1, 1995
Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian speciesJ Taylor, B Meignier, J Tartaglia, et al.
Avian Diseases|January 1, 1996
Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challengeJ Taylor, L Christensen, R Gettig, et al.
Pageof 21

Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
Contributions to Nephrology|January 1, 1987
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestionG Deferrari, G Garibotto, C Robaudo, et al.
Virology|November 1, 1991
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virusE Konishi, S Pincus, B A Fonseca, et al.
Veterinary Microbiology|December 1, 1993
Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant virusesS L Brockmeier, K M Lager, J Tartaglia, et al.
Vaccine|August 1, 1995
Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidateE Gönczöl, K Berensci, S Pincus, et al.
Journal of Virology|January 1, 1995
Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 geneE Beattie, K L Denzler, J Tartaglia, et al.
Virology|September 1, 1992
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swineE Konishi, S Pincus, E Paoletti, et al.
The Journal of Infectious Diseases|June 1, 1987
Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein DM Wachsman, L Aurelian, C C Smith, et al.
Virology|December 1, 1990
Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase geneC Edbauer, R Weinberg, J Taylor, et al.
Vaccine|April 1, 1995
Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian speciesJ Taylor, B Meignier, J Tartaglia, et al.
Avian Diseases|January 1, 1996
Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challengeJ Taylor, L Christensen, R Gettig, et al.
Pageof 21